Hospital Pharmacy Europe - Cardiovascular medicine,

Click here

Saturday 25 May 2013 Register Login

You are here:

Suppliers Guide

New neurology product

Hospital Pharmacy Europe is assisting with a survey on messaging for a new neurology product. Click here

LATEST ISSUE

Contamination control and preparation of anticancer drugs, medicines reconciliation, Ruconest drug evaluation, ivacaftor for cystic fibrosis , oxycodone-naloxone prolonged-release tablets, IV chemotherapy, capsaicin in the treatment of severe neuropathic pain, alitretinoin in severe chronic hand eczema, Zyclara for actinic keratoses

Pharmacy Zone: Cardiovascular medicine

Magazine	Sponsored content
News	Video

Page:

1

Fri 24 May

Post-approval transcatheter aortic valve implantation
One-year results from SOURCE XT – one of the largest, post-approval transcatheter aortic valve implantation (TAVI)...

Wed 8 May

Bayer HealthCare joins forces with Stroke Alliance for Europe
Ahead of the 'Move for Health Day' (10 May) and the 'European Stroke Day' (14 May), the Stroke Alliance for Europe (SAFE) and...

Fri 26 Apr

Binge drinking found to impair vascular function
History of repeated binge drinking in healthy young adults caused alterations in macro- and microvascular function similar to...

Tue 2 Apr

Levosimendan: review of recent clinical data
Levosimendan is a cardioprotective inodilator, with unique mechanisms of action and a beneficial effect on survival and length of...

Fri 22 Mar

Xarelto® recommended for approval in the EU
The European Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Bayer HealthCare’s oral...

Tue 12 Mar

Metalyse® pharmaco-invasive strategy
New data presented at the American College of Cardiology 62nd Annual Scientific Sessions and Expo demonstrate that patients with...

Tue 12 Mar

COMMANDER-HF Phase III clinical trial
Bayer HealthCare and its cooperation partner Janssen Research & Development, LLC announced today the initiation of...

Tue 12 Mar

PIONEER AF-PCI Phase IIIb clinical study
Bayer HealthCare announced today the initiation of the PIONEER AF-PCI study, a Phase IIIb clinical study of its oral...

Thu 7 Mar

Response letter for Bayer’s Xarelto®
Bayer HealthCare has announced that the US Food and Drug Administration (FDA) issued a second complete response letter regarding...

Fri 1 Mar

Arterial clot prevention
Bayer HealthCare has announced that new data from the clinical development programme supporting its oral anticoagulant...

Wed 13 Feb

Mallinckrodt will promote and distribute Rapiscan® in France, Italy, Belgium, and Spain
Rapidscan Pharma Solutions (RPS) EU Ltd has announced that they have come to agreement with Mallinckrodt Medical BV...

Wed 13 Feb

Eliquis use within NHS Scotland for the prevention of stroke and systemic embolism
Bristol-Myers Squibb and Pfizer Ltd. has announced that the Scottish Medicines Consortium (SMC) accepted the novel oral...

Tue 12 Feb

Bayer’s Riociguat submitted for regulatory approval in the US and EU
Bayer HealthCare has submitted the oral investigational drug riociguat to treat patients with inoperable chronic thromboembolic...

Fri 8 Feb

European patient registry in venous thromboembolism (VTE)
Daiichi Sankyo Europe GmbH announced the enrolment of the first patient into the PREvention oF thromboembolic events - European...

Thu 24 Jan

NICE Final Appraisal Determination on ELIQUIS®
Bristol-Myers Squibb and Pfizer Ltd. have announced that the National Institute for Health and Clinical Excellence (NICE) has...

Tue 15 Jan

Niacin/laropiprant products to be suspended worldwide
The European Medicines Agency (EMA) has recommended that the marketing, supply, and authorisations of three identical...

Tue 15 Jan

The world’s premier cardiovascular congress goes to Amsterdam
Amsterdam is preparing for the arrival of more than 30,000 participants for this year’s ESC Congress. As the world’s...

Thu 6 Dec
2012

Xarelto® approved for the treatment of PE and the prevention of DVT
Bayer HealthCare’s oral anticoagulant Xarelto® (rivaroxaban) has been approved by the European Commission (EC) for the...

Wed 5 Dec
2012

Atherosclerosis found in HIV children
Children with HIV have a 2.5 fold increased risk of atherosclerosis, according to research presented at EUROECHO and other...

Tue 4 Dec
2012

Warfarin risk highest in first 30 days of therapy
Haemorrhage rates in older atrial fibrillation (AF) patients exceed those reported in clinical trials, according to a study...

Page:

1

Web design, hosting and programming by ModeZero